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, THE PRINCIPLE SECRETORY PRODUCT of the thyroid gland, is a prohormone and must be monodeiodinated at the outer ring to form the active hormone 3,5,3=-triiodothyronine (T 3 ). Virtually all of the physiological effects of thyroid hormone are generated by the interaction of T 3 with its nuclear receptors. In humans, ϳ80% of the T 3 is derived from monodeiodination catalyzed by either the type I (D1) or the type II (D2) selenodeiodinase. The type I enzyme, highly expressed in liver, kidney, and the thyroid gland, is located in the plasma membrane with its active center in the cytosol. It is inhibited by the thiourea drug 6n-propylthiouracil (PTU) and provides much of the T 3 for the circulation (10) . On the other hand, D2 is expressed in pituitary, central nervous system, thyroid, bone, brown adipose tissue and skeletal muscle (1, 29) . It is insensitive to PTU and is located in the endoplasmic reticulum, with its active center in the cytosol. Programmed or induced changes in D2 expression permit tissue-specific changes in intracellular T 3 concentrations (1, 6, 10) . Studies in rats have demonstrated that tissues expressing D2 contain nuclear thyroid receptor-bound T 3 derived from two sources: the plasma, termed T 3 (T 3 ), and D2-mediated intracellular T 4 -to-T 3 conversion, termed T 3 (T 4 ). The contribution of each to receptor occupancy varies among different tissues. The nuclear T 3 in tissues not expressing D2, such as the D1-expressing liver and kidney, is almost exclusively T 3 (T 3 ) (1, 10, 27) . The importance of the distinction between the two sources is that T 3 (T 4 ) production can be regulated in specific cells or tissues by various pathways such as cyclic AMP or FoxO3, in addition to being negatively regulated by T 3 (transcriptionally) or T 4 (postranslationally), whereas T 3 (T 3 ) is regulated by the hypothalamic-pituitary-thyroid axis (1, 3, 4, 6) . In addition, D2-generated T 3 (T 4 ) allows for local increases in receptor occupancy, while circulating levels of T 3 (T 3 ) remains unchanged.
D2 mRNA was identified in human skeletal muscle many years ago, but its physiological role has not been well defined because of its low activity (2, 20) . Recent improvements in the assays of muscle D2 activity show that it is clearly present and higher in slow than in fast muscles (7, 13, 18) .
Gene targeting techniques and studies using D2 inhibitors indicate that, despite the low expression of the D2 protein, D2-mediated T 4 -to-T 3 conversion is required for normal differentiation of neonatal skeletal muscle and C 2 C 12 mouse myoblast cells (4) . After skeletal muscle injury in vivo, there is a marked increase in D2 activity, peaking 7-12 days after injury (4) . Notably, in D2KO mice or mice haploinsufficient for FoxO3, muscle regeneration after injury is significantly delayed. Since circulating T 3 concentrations are normal and not influenced by injury in D2KO mice, this suggests a critical role for D2-mediated T 3 (T 4 ) during the regeneration process and perhaps even under basal conditions, but this has not been demonstrated. The goal of the present studies was to determine whether D2-mediated intracellular T 3 (T 4 ) production occurs in mouse skeletal muscle, and if so, whether this increases during muscle regeneration in parallel with increased D2 activity.
MATERIALS AND METHODS

Reagents and Materials
Unless otherwise specified, all reagents were purchased from Sigma (St. Louis, MO). Outer ring-labeled 125 I-T4 (specific activity 4,400 Ci/mmol) was purchased from PerkinElmer.
131 I-T3 was pre-pared in the laboratory by iodination of 3,5-diiodothyronine, using chloramine T and purified by paper chromatography (25) .
In vitro Studies
Cell cultures. C2C12 cells were obtained from ATCC. Primary cultures of skeletal muscle cells enriched in satellite cells (pp6 cells) were isolated from C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) as previously described (4, 17) . The cells were cultured in DMEM containing 1 ng/ml ␤-FGF, 5 ng/ml IGF-I, 10% horse serum, and 10% FBS (proliferating conditions). They were induced to differentiate by removing the FBS, reducing the horse serum to 2%, and adding insulin, transferrin, and Na 2SO3 (differentiation medium) (4) . To assess the effect of differentiation-induced D2 on the ratio of 125 I-T3(T4) to 131 I-T3(T3) we incubated proliferating and differentiated cells overnight in 0.1% BSA containing free 125 I-T4 (27 pM) and free 131 I-T3 (4 pM) in 60-mm dishes for 22 h in 1.5 ml of DMEM (11) . In some experiments, 30 nM reverse (r)T3 was included to block D2 activity (26) .
Preparation of nuclei and cytosol and quantitation of 125 I-T3, 131 I-T3, and 125 I-T4. Nuclei and cytosol were prepared using differential centrifugation as previously described (22) . Nuclear pellets were extracted with 100% ethanol-ammonium hydroxide (99:1) and chromatographed on 3-mm Whatman chromatography paper using tertiary amyl alcohol-hexane-ammonium hydroxide for 24 -48 h together with unlabeled iodide, T 4, T3, and 10 Ϫ3 M PTU as described (15, 24) . The locations of labeled T3 and T4 on the strips were identified by colorimetry: appropriate segments of paper were counted in a dualchannel spectrometer. The counts of 125 I-T3 were corrected for the 29% crossover of 131 I-T3 appearing in the 125 I-T3 window. The net 125 I-T3 was multiplied by 2 to correct for loss of an 125 I atom from the distal ring of 125 I-T4 and the ratio of 125 I-T3 to 131 I-T3 determined. Aliquots of cytosol (ϳ30% of the total cytosol fraction) were treated in the same way.
D2 deiodination assays. D2 activity was measured in cell homogenates as previously described (21) .
In vivo Studies
Four to five 8-to 12-wk-old WT C57BL/6 males, age-matched within each experiment, were obtained from Jackson Laboratories. D2KO mice generated were back-crossed 11 times into the C57BL/6 line (23). In some experiments, mice were made hypothyroid by providing drinking water containing 0.1% methimazole (MMI) and 1% NaClO 4 (MMI/ClO4) for 8 wk (13) . Muscle regeneration was induced by cardiotoxin injection as described previously (4, 30) . Briefly, 25 l of 10 M cardiotoxin (Calbiochem) was injected into the right anterior tibialis (AT) and 50 l into the gastrocnemius (GC) muscles of isofluorane-anesthetized C57BL/6 age-and sex-matched WT and D2KO mice. The corresponding left AT and GC muscles were not injected and used as controls. Studies were performed 9 days after injury, which is the period of peak D2 expression using this approach (4). Serum T 3 and T4 were unchanged in these mice (4) .
Mice received an injection of 125 I-T4 (ϳ20 Ci/animal ip) 24 h prior to being euthanized. On the day of the experiment each animal was given ϳ5 Ci ip of 131 I-T3 4 h prior to obtaining tissues. PTU (1 mg/100 g body wt ip) was administered 48, 24, and 6 h before tissue harvest to inhibit D1 activity in liver and kidney. Assays of liver homogenates confirmed 90% blockade of D1 activity in treated mice. Animals were anesthetized with isofluorane, and blood was collected via cardiac puncture, after which they were perfused with ice-cold 0.14 M NaCl containing 10 Ϫ4 M PTU to remove residual blood. Tissues (skeletal muscles, liver, kidney, and cerebral cortex) were collected, homogenized in 10 vol wet/wt of Tris buffer, pH 7.5, 10
Ϫ4
M PTU containing protease inhibitor (Roche). Cytosol was obtained via low-speed centrifugation (3,300 rpm ϫ 5 min) at 4°C. All animal experimental protocols were approved by the Animal Research Committee of Harvard Medical School.
Statistics
Prism 4.0 software (GraphPad Software, San Diego, CA) was used for statistical analysis. When only two groups were analyzed, statistical significance was determined by an unpaired Student's t-test. Two-way ANOVA was used to compare the effects of different treatments on two different cell types (proliferating and differentiated cells) or on two different genotypes (WT vs. D2KO) followed by t-test when significant differences were found. Results shown are means Ϯ SE. P Ͻ 0.05 was considered statistically significant.
RESULTS
D2 is Expressed in Muscle Precursor Cells and Increases Nuclear and Cytosolic T 3
D2 mRNA is increased during differentiation in C 2 C 12 cells and in neonatal mouse skeletal myoblasts (4) . After 48 h of incubation in differentiation media, D2 activity in C 2 C 12 cell sonicates increased fourfold, from 0.35 Ϯ 0.01 to 1.7 Ϯ 0.01 fmol·min Ϫ1 ·mg protein Ϫ1 (P Ͻ 0.0001), in differentiated compared with proliferating cells. To determine whether the increase in D2 was reflected in changes in intracellular T 3 (T 4 ), proliferating and differentiated C 2 C 12 cells were incubated overnight in 125 I-T 4 and 131 I-T 3 containing media supplemented with unlabeled hormone at physiological concentrations, and nuclear and cytosolic 125 I-T 3 and 131 I-T 3 were isolated. The ratio 125 I-T 3 / 131 I-T 3 was fourfold higher in differentiated vs. proliferating C 2 C 12 cells in both the nucleus and the cytosol (Fig. 1, A and B) . In both proliferating and differentiated cells, nuclear T 3 binding of both isotopically labeled T 3 molecules was blocked by high concentrations of unlabeled T 3 , indicating that nuclear T 3 binding was saturable and specific (data not shown).
rT 3 (3,3=,5=-triiodothyronine) is a competitive inhibitor of D2-mediated T 4 -to-T 3 conversion, which also selectively reduces D2 activity by promoting its ubiquitination, thus accelerating its proteasomal degradation (26) . We found that the inhibitory effect of rT 3 is dependent on cell differentiation (two-way ANOVA interaction, P Ͻ 0.001). Treatment with 30 nM rT 3 reduced the 125 I-T 3 / 131 I-T 3 ratio in the nuclei of differentiated cells to levels not different from that in nuclei of proliferating C 2 C 12 cells (Fig. 1, A and B) . The same treatment had no effect on the 125 I-T 3 / 131 I-T 3 ratio in proliferating C 2 C 12 cells, consistent with much lower D2 activities in the proliferative phase. These observations establish a role for D2 in this model of mouse skeletal muscle cell precursors in generating intracellular T 3 , which in turn is bound to the thyroid nuclear receptors. Reverse T 3 had no effect on the nuclear 131 I-T 3 (Figs. 1, C and D) , indicating that the reduction in the 125 I-T 3 / 131 I-T 3 ratio with rT 3 -treated cells was not due to enhanced cellular 131 I-T 3 uptake. Thus, the increased 125 I-T 3 in differentiated C 2 C 12 cells reflects an increase in D2-mediated T 3 (T 4 ) production.
pp6 cells are dispersed neonatal (P3-P4) mouse myoblasts enriched with satellite cells expressing Pax7 (16) . The expression of D2 mRNA, while detectable in the proliferative phase, markedly increases after differentiation (4) . In agreement with this, in pp6 cells, D2 activity increases eightfold, from 0.01 Ϯ 0.01 to 0.08 Ϯ 0.2 fmol·min Ϫ1 ·mg protein Ϫ1 (P Ͻ 0.01). In experiments analogous to those performed in C 2 C 12 cells, the ratio of 125 0.05 (P Ͻ 0.001) and 2.7 Ϯ 0.5 vs. 1.0 Ϯ 0.05 (P Ͻ 0.05)] in nuclei and cytosol, respectively (Fig. 2, A and B) . Exposure to rT 3 eliminated this difference (Fig. 2, A and B) , confirming that the effect of treatment depended on the cell differentiation status (two-way ANOVA interaction, P Ͻ 0.001 and P Ͻ 0.05 in nuclei and cytosol, respectively). As in C 2 C 12 cells, no differences were found in 131 I-T 3 in either nuclei or cytosol in proliferating and differentiated cells (Fig. 2, C  and D) , confirming that the higher ratios of 125 I-T 3 to 131 I-T 3 in the differentiated cells is due to an increase in D2-mediated T 3 production. Also, rT 3 did not reduce cytosolic 125 I-T 4 in pp6 cells, indicating that its effect to decrease 125 I-T 3 formation was not due to a reduction of 125 I-T 4 uptake (data not shown).
D2 Increases Intracellular T 3 (T 4 ) In Vivo in Adult Mouse Skeletal Muscle and Cerebral Cortex
We next examined whether D2-mediated T 4 -to-T 3 conversion contributed to intracellular T 3 in vivo using a similar dual isotopic approach. Since there have been no previous studies of this issue in the mouse, we studied two D2-expressing tissues (skeletal muscle and cerebral cortex) and compared these with the D1-expressing (but D2-null) liver and kidney. The latter two tissues should not form intracellular T 3 (T 4 ), since the T 3 formed by D1 rapidly exits the cell (10).
Intracellular T 3 (T 4 ) is Present in D2-Expressing Tissues of Adult Mice
To evaluate the role of D2 in vivo, we injected WT and D2KO mice with 125 I-T 4 and 131 I-T 3 , 24 and 4 h, respectively, prior to harvesting cerebral cortex, skeletal muscle, liver, and kidney for isolation of labeled T 3 . The sera of these mice contain 131 I-T 3 and 125 I-T 3 , the latter generated from 125 I-T 4 by either D1-or D2-mediated deiodination. To minimize the contribution of D1 to the 125 I-T 3 production and facilitate identification of the D2-generated product, all mice were treated with PTU to inhibit D1 activity prior to tracer T 4 injection (see MATERIALS AND METHODS). Because hypothyroidism increases D2 activity and reduces that of D1 in liver and kidney, further reducing the D1-generated 125 I-T 3 , we first examined hypothyroid WT and D2KO mice (Fig. 3) . The 125 I-T 3 / 131 I-T 3 ratio in WT sera was 2.85 Ϯ 0.05-fold higher than that in the sera of D2KO mice (P Ͻ 0.001), indicating a significant contribution of D2-generated 125 I-T 3 to the sera of hypothyroid mice. Since T 3 derived from serum will enter the tissues, this difference in isotope ratios between the WT and D2KO mice must be taken into account when the ratio of 125 I-T 3 131 I-T3 in nuclear extracts (C) or cytosol (D) were normalized as in A and B. Data are means Ϯ SE of triplicates of 3 independent experiments. **P Ͻ 0.01; ***P Ͻ 0.001; ns, not significant.
T 3 /
131 I-T 3 ratio in WT tissues (after correction for that in the serum) will be significantly higher than in tissues from D2KO mice. The 125 I-T 3 / 131 I-T 3 ratio in the hypothyroid WT cerebral cortex is 14-fold higher than that in D2KO mice (Fig. 3A and Table 1 ). The corrected 125 I-T 3 / 131 I-T 3 ratio in skeletal muscle is 3.5-fold greater in WT than in D2KO mice (Fig. 3B) . In contrast, in WT liver and kidney, the 125 I-T 3 / 131 I-T 3 ratio is not different from that in D2KO mice (Fig. 3, C and D Fig. 1 legend) . Data are means Ϯ SE of triplicates of 3 independent experiments. *P Ͻ 0.05, ***P Ͻ 0.001. 131 I-T 3 ratios (corrected for that in the serum) between WT and D2KO mice are smaller but qualitatively the same as in the hypothyroid mice (Fig. 4 and Table 1 ). In the cerebral cortex, the corrected 125 I-T 3 / 131 I-T 3 ratio is threefold higher in WT and in skeletal muscle twofold higher than in the D2KO mice (Fig. 4, A and B, and Table 1 ; P Ͻ 0.05). The 125 I-T 3 / 131 I-T 3 ratios in the liver and kidney of WT mice are not different from those in the D2KO mice, indicating no significant production of T 3 (T 4 ) in these D1-expressing tissues (Fig. 4, C and D) . To compare the results of the same tissue between euthyroid and hypothyroid mice, it is necessary to normalize the WT results by dividing the corrected ratios by the average 125 I-T 3 / 131 I-T 3 ratio in the same tissues of the D2KO mice (Table 1) . That is required because the amounts of labeled T 3 and T 4 given to the mice varied slightly between animals and experiments. The magnitude of that ratio is a rough estimate of the net D2-mediated T 3 production in a given tissue. The 125 I-T 3 / 131 I-T 3 ratio is significantly higher in the hypothyroid cerebral cortex than in skeletal muscle compared with same tissues in euthyroid animals (Table 1) , consistent with the higher D2 expression in hypothyroidism.
The Increase in D2 During Muscle Regeneration Increases Local T 3 (T 4 ) in Injured Tissue
Injury to skeletal muscle causes an increase in D2 mRNA and activity, which peaks six-to eightfold above basal levels at about 8 days after the injury (4). In D2KO mice, regeneration is impaired, and the normal postinjury increase in the T 3 -dependent myoD does not occur. We hypothesized that the increase in D2 provided additional T 3 (T 4 ), which was necessary for the transcriptional increase in myoD and its downstream targets (4). We tested this by examining the 125 I-T 3 / 131 I-T 3 ratio in cytosol of AT and GC muscle in mice given labeled iodothyronines 8 days after cardiotoxin injection (Fig. 5) . Results were compared with the corresponding uninjected muscle in the contralateral leg in both WT and D2KO mice. The effect of the injury was D2 dependent (two-way ANOVA interaction, P Ͻ 0.05). In WT animals, there was a twofold higher I-T 3 ratios than do WT mice, and these do not change after injury. These results were confirmed in a second experiment.
DISCUSSION
We are not aware of other studies of the relative contribution of T 3 (T 3 ) and T 3 (T 4 ) in mouse tissues. Previous molecular physiological results with C 2 C 12 myoblasts, pp6 cells, and whole animals suggest that skeletal muscle is T 3 deficient when D2 is chemically inhibited or the dio2 gene is inactivated (4). Consistent with this, in vitro results in cultured cells show decreased expression of T 3 -dependent genes, such as myoD and its downstream T 3 -dependent gene products. This corresponds with a delay in differentiation, which can be rescued by Table 1 
. Effect of hypothyroidism on the ratio of T 3 (T 4 )/T 3 (T 3 ) in wild-type vs. D2KO in D2-and D1-expressing tissues
Results are means Ϯ SE of the ratios of 125 I-T3/ 131 I-T3 in each wild-type mouse divided by the corresponding ratio for the D2KO mouse in that same group. T3, triiodothyronine; T4, thyroxine; D1 and D2, types I and II iodothyronine deiodinase; NS, not significant. Fig. 4 .
125 I-T3(T4)/ 131 I-T3(T3) ratio is higher in cytosol of cerebral cortex (A) and skeletal muscle (B) from euthyroid WT than from D2KO mice but not different in liver (C) and kidney (D) cytosol. Assessment of 125 I-T3/ 131 I-T3 ratios in tissue cytosol extracts from WT and D2KO mice that received 125 I-T4 and 131 I-T3 for 24 and 4 h, respectively, prior to obtaining tissues (see Fig. 3 legend) . As in Fig. 3 , observed ratios were corrected by dividing by the serum 125 I-T3/ 131 I-T3 ratio. Results are means Ϯ SE of 4 animals per group. *P Ͻ 0.05. overexpression of D2 or by exposing the cells to pharmacological T 3 concentrations (30 nM) (4). In agreement with this, in D2KO animals, or if D2 expression is reduced due to a haploinsufficiency of the FoxO3 gene, the postinjury regeneration process is impaired (4, 8) . The present experiments directly show that D2 provides intracellular T 3 (T 4 ) to the nuclei of skeletal muscle cells in vitro and that its inhibition in vitro or inactivation in vivo reduces the intracellular T 3 , despite normal circulating serum or media T 3 concentrations. This work directly addresses the role of D2 in normal differentiation and regeneration.
In both C 2 C 12 and pp6 cells, differentiation resulted in morphological changes in the cells, as previously documented, and a six-to eightfold increase in D2 expression, suggesting there is a relationship between these two events (5). We found that in proliferating cells the 125 I-T 3 / 131 I-T 3 ratio in nuclei and cytosol incubated with physiological free concentrations of T 4 and T 3 was much lower than after differentiation when D2 is increased (Figs. 1 and 2A) . When differentiated C 2 C 12 or pp6 cells were incubated with rT 3 to accelerate proteasomal degradation of D2, only 125 I-T 3 was reduced, resulting in a marked decrease in the 125 I-T 3 / 131 I-T 3 ratio. rT 3 treatment did not either block the 125 I-T 4 uptake or increase the amount of 131 I-T 3 bound to the nuclei. Thus, the decrease in the 125 I-T 3 / 131 I-T 3 ratio reflected a decrease in D2-mediated T 4 -to-T 3 conversion (Figs. 1 and 2) .
Results in vivo confirm that T 3 (T 4 ) contributes to intracellular T 3 in D2-expressing tissues but not in those expressing only D1, since the 125 I-T 3 / 131 I-T 3 ratio in each D1-containing tissue is the same as that found in the serum. This is analogous to the situation in the rat (10) . A comparison of the tissue-toserum ratios of 125 I-T 3 / 131 I-T 3 in euthyroid and hypothyroid WT as opposed to D2KO mice further validates this strategy. In hypothyroid mice, in which D2 activity is elevated, these ratios were 14-and 3-fold higher in cerebral cortex and skeletal muscle, respectively, of WT vs. D2KO mice but not different in D1-containing liver or kidney ( Fig. 3 and Table 1 ). The higher values for the tissue-to-serum ratios in the hypothyroid D2-expressing tissues illustrates that there is a quantitative relationship between the amount of T 3 (T 4 ) produced and D2 expression (13) .
While more tracer T 3 (T 4 ) is formed in hypothyroid than in euthyroid tissues, it should be kept in mind that the serum T 4 is much lower in hypothyroidism, so that the higher 125 I-T 3 / 131 I-T 3 ratio indicates that the tracer, not the gravimetric, T 3 production rates are increased in hypothyroid D2-expressing tissues. This contrasts with the situation in regenerating skeletal muscle, where there is up to a sixfold increase in D2 activity, which peaks about 8 -9 days after skeletal muscle injury in euthyroid animals (4) . Since this increase occurs in the presence of a normal circulating T 4 , the amount of T 3 generated is significantly increased (Fig. 5) , confirming the physiological role of D2 in inducing myoD expression and other changes during the healing process (4) . No change of 125 I-T 3 / 131 I-T 3 above the basal ratio was observed in D2KO mice after injury, as expected. D2KO mice are insulin resistant and susceptible to diet-induced obesity, and bile acids stimulate UCP3 mRNA in skeletal muscle through a T 4 -dependent process (12, 19, 28) . These features may reflect other physiologically relevant actions of the intracellular T 3 supplied by skeletal muscle D2.
With respect to humans, about 80% of daily T 3 production derives from peripheral T 4 monodeiodination. The relative roles of D2 vs. D1 in serum T 3 production have not been defined, although there are significant reductions in the serum T 3 /T 4 ratio in humans with a mutation in the selenocysteine insertion sequence (SBP-2), which is required for both D1 and D2 synthesis (5). It has not been possible to quantitate the degree of impairment of D1 in those individuals, but D2 expression is significantly reduced in cultured fibroblasts. A decrease of D2 in the hypothalamic-pituitary axis can also explain the compensatory increases in TSH and T 4 secretion in those patients. In individuals with high D2-expressing metastatic thyroid carcinoma, the ratio of circulating T 3 to T 4 is markedly increased, again confirming that D2-mediated generation of T 3 from T 4 can contribute significantly to circulating T 3 (9, 14) .
Taken together, our data establish that the D2 present in mouse skeletal muscle provides a significant contribution to the intracellular T 3 under basal circumstances. Increases in D2, such as occur in the postnatal period or following injury, are sufficient to provide an increase in intracellular T 3 in this tissue, as long as serum T 4 remains constant. Thus, skeletal muscle, like the pituitary, central nervous system, and brown adipose tissue, is a tissue in which alterations in D2 activity can influence the local T 3 concentration and thereby alter the expression of T 3 -dependent genes.
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